The price of ECVT is predicted to go up 1.3%, based on the high correlation periods with MHK. The similarity of these two price pattern on the periods is 93.7%.
ECVT
MHK
Up: 1.3%Similarity: 93.7%
ECVT Revenue Forecast
ECVT EPS Forecast
ECVT FAQs
What is bull’s view on ECVT?
ECVT stock is currently trading at $8.61, with a 52-week range of $6.02 to $11.35. Bulls argue that the stock's recent cross above its 200-day moving average signals potential upward momentum, supported by its relatively low valuation (P/E ratio of 13.93) and management's confidence shown through aggressive share buybacks. Additionally, long-term growth opportunities in sustainable aviation fuel and advanced recycling technologies could drive future gains.
What is bear's view on ECVT?
ECVT stock is currently trading at $7.76, down 0.89% from the previous close. The bearish view stems from its weak financial performance, including a Q3 EPS miss and a 12% decline in adjusted EBITDA year-over-year, reflecting operational challenges. Additionally, the stock is near its 52-week low, signaling limited investor confidence and potential downside risk.
What is ECVT revenue forecast for next quarter?
The market consensus for ECVT's revenue in the upcoming quarter is projected to be approximately $171.888M USD.
What is ECVT eps forecast for next quarter?
The market consensus for ECVT's eps in the upcoming quarter is projected to be approximately $0.087 USD.
Citi analyst Patrick Cunningham raised the firm's price target on Ecovyst to $9 from $8 and keeps a Buy rating on the shares. The firm updated estimates, price targets, and ratings in conjunction with its 2025 chemicals outlook. Citi maintains a "broadly neutral view" on commodity chemicals, saying most chains have some form of supply overhang and the first half of 2025 earnings are looking very similar to the second have of 2024. The firm says its top picks are reflective of confidence on long-term earnings power and durable competitive advantages at reasonable valuations in the cases of Ecolab (ECL) and Corteva (CTVA), and a "compelling" activist campaign in the case of Air Products (APD).